WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Ownership - Who owns Agios Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Agios Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jacqualyn A. FouseDirector2025-04-107,497$25.90
$194.17kSell
Tsveta MilanovaChief Commercial Officer2025-03-031,681$35.54
$59.74kSell
Cecilia JonesChief Financial Officer2025-03-031,681$35.54
$59.74kSell
Theodore James Washburn Jr.Principal Accounting Officer2025-03-03727$35.54
$25.84kSell
Sarah GheuensChief Medical Officer2025-03-031,137$35.54
$40.41kSell
Sarah GheuensChief Medical Officer2025-03-031,187$35.54
$42.19kSell
Sarah GheuensChief Medical Officer2025-03-031,681$35.54
$59.74kSell
Theodore James Washburn Jr.Principal Accounting Officer2025-03-03697$35.54
$24.77kSell
Theodore James Washburn Jr.Principal Accounting Officer2025-03-03231$35.54
$8.21kSell
Brian GoffChief Executive Officer2025-03-034,153$35.54
$147.60kSell

1 of 4

AGIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGIO insiders and whales buy or sell their stock.

AGIO Shareholders

What type of owners hold Agios Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene European Investment Co LLC10.24%5,867,279$170.74MInsider
Farallon Capital Management LLC9.90%5,674,466$165.13MInstitution
Vanguard Group Inc9.83%5,631,321$163.87MInstitution
Blackrock Inc8.75%5,016,260$145.97MInstitution
Robert Nelsen6.93%3,969,968$115.53MInsider
Bellevue Group Ag6.14%3,515,150$102.29MInstitution
Arch Venture Fund VII LP5.39%3,088,590$89.88MInsider
Celgene Corp4.34%2,486,157$72.35MInsider
Price T Rowe Associates Inc4.23%2,423,537$70.52MInstitution
Armistice Capital LLC3.95%2,264,304$65.89MInstitution

1 of 3

AGIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGIO75.63%24.37%Net SellingNet Selling
IRON50.85%49.15%Net BuyingNet Selling
HRMY71.11%28.89%Net SellingNet Selling
BEAM81.81%18.19%Net SellingNet Selling
ARWR79.12%10.88%Net SellingNet Selling
View Top Biotech Stocks

Agios Pharmaceuticals Stock Ownership FAQ

Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals (NASDAQ: AGIO) is owned by 104.39% institutional shareholders, 33.64% Agios Pharmaceuticals insiders, and 0.00% retail investors. Celgene European Investment Co LLC is the largest individual Agios Pharmaceuticals shareholder, owning 5.87M shares representing 10.24% of the company. Celgene European Investment Co LLC's Agios Pharmaceuticals shares are currently valued at $174.20M.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.